National Consumer Alert on 7-OH Products Posing Significant Dangers
The U.S. Food and Drug Administration (FDA) has recently issued multiple warning letters to companies selling these adulterated and illegal products, making it unequivocally clear: 7-OH products are unsafe, misleadingly marketed, and violate federal law.
Why Consumers Should Be Concerned
Retailers and Manufacturers Beware
The AKA applauds the FDA's long-overdue action to protect consumers and remove these hazardous products from the marketplace. For years, AKA has advocated for commonsense regulations through state-level Kratom Consumer Protection Acts (KCPAs) that clearly prohibit dangerous alkaloid manipulation, including limits on 7-OH to no more than 2% of total alkaloid content—a threshold that corresponds with less than 1 mg per serving.
What Consumers Can Do
Additional Resources
The Bottom Line: If it's not natural kratom, it's not kratom.
About American Kratom Association (AKA)
American Kratom Association (AKA) is a consumer-based, nonprofit organization, focused on furthering the latest science as guidance for kratom public policy. AKA works to give a voice to millions of Americans by fighting to protect their rights to access safe and natural kratom. For more information, visit americankratom.org and learn more at kratomanswers.org.
Media Contact
Mac Haddowpress@americankratom.org
###
SOURCE: American Kratom Association (AKA)
Copyright 2025 EZ Newswire
See release on EZ Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
8 minutes ago
- The Independent
US cities have seen an 80 percent increase in extreme heat streaks
Life-threatening heat waves and consecutive hot days, known as heat streaks, are increasingly affecting US cities due to human-caused climate change. A report by the non-profit Climate Central revealed an 80 percent increase in extreme heat streaks across 247 analyzed US cities, with 198 cities experiencing two more streaks annually than in the early 1970s. Cities in the Southwest, Northeast, Ohio Valley, and Southeast, including Nashville and Raleigh, have seen the most significant rise in heat streak frequency. Prolonged heat poses severe risks, such as increased heat-related illnesses, worsened air quality, and strain on electrical grids, with heat being the leading cause of weather-related deaths in the US, accounting for 2,325 deaths in 2023. A new heat wave is currently impacting 100 million Americans, bringing temperatures up to 15 degrees Fahrenheit above average and 'feels like' temperatures potentially reaching 115 degrees Fahrenheit in some regions.
Reuters
2 hours ago
- Reuters
FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy
July 25 (Reuters) - The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who received Sarepta Therapeutics' (SRPT.O), opens new tab muscular disorder gene therapy Elevidys. The death occurred on June 7, the agency said, sending shares of the company down more than 3% in extended trading. The patient with Duchenne muscular dystrophy, who died in Brazil, was treated with Elevidys but was not a participant in a clinical trial, Roche, which partners with Sarepta outside the U.S., told Reuters in an email. The reporting physician has assessed the death as unrelated to treatment with the gene therapy, Roche said, adding that the death was reported to the health authorities as required per local regulations, and that it was continuing to gather and analyze the information from this event. Sarepta has come under intense regulatory scrutiny after two non-ambulatory teenage boys died due to acute liver failure associated with Elevidys, and a 51-year-old man who had received its experimental gene therapy SRP-9004 died from the same condition. Late on Monday, the company said it would comply with a request from the FDA to pause all shipments of Elevidys in the United States. Its partner Roche also paused Elevidys shipments in some countries outside the U.S. later. The FDA's request had come after the company disclosed the death of the patient on SRP-9004.
Reuters
3 hours ago
- Reuters
Kennedy to oust care task force, WSJ reports; HHS says no decision yet
WASHINGTON, July 25 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer screenings and other preventive health measures insurers must cover, the Wall Street Journal reported on Friday, citing people familiar with the matter. A Department of Health and Human Services spokesperson said on Friday that Kennedy had not yet made a decision regarding the 16-member U.S. Preventive Services Task Force. "No final decision has been made on how the USPSTF can better support HHS' mandate to Make America Healthy Again," the HHS spokesperson said. The Journal said Kennedy planned to dismiss all 16 panel members in what would be the latest in a series of far-reaching actions by Kennedy, a long-time vaccine skeptic, to reshape U.S. regulation of vaccines, food and medicine. In June he fired all 17 members of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, a panel of vaccine experts, replacing them with seven handpicked members, including known vaccine skeptics. The USPSTF includes medical experts serving staggered four-year terms on a volunteer basis. Its role in choosing what services will be covered by insurers was established under the 2010 Affordable Care Act, also known as Obamacare. The 40-year-old group, whose recommendations provide guidance to doctors, looks at everything from routine breast cancer screening to drugs to prevent HIV infection. The U.S. Supreme Court in June upheld the constitution of the task force and ruled in favor of its recommendation to cover preventive care. Though made up of an independent group of volunteer experts, members are selected by the health secretary without Senate confirmation and it relies on support from the department's Agency for Healthcare Research and Quality. A group of 104 health organizations, opens new tab, including the American Medical Association and the American Academy of Pediatrics, in early July sent a letter to Congressional health committees, urging them "to protect the integrity" of the task force. The task force has been criticized by some conservatives, opens new tab as too left-leaning.
